JAZZ 8-K 2026-09-23

Jazz Pharmaceuticals plc (JAZZ) 8-K dated 2026-09-23 — accession 0001193125-26-399425. This URL is the filing, not the JAZZ hub.

Jazz Pharmaceuticals plc (JAZZ) is a biotechnology company listed on US.

Jazz Pharmaceuticals plc filed a 8-K on 2026-09-23. Accession 0001193125-26-399425.

Cached items: 1.01, 2.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported JAZZ revenue for 2025-12-31 was $4.27B. Net income was -$356.1M. Revenue was up 4.9% from 2024-12-31 to 2025-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.

Not investment advice. The JAZZ SEC hub lists recent forms. The stock page is the research view.